Topotecan Hospira 4 mg/4 ml concentrate for solution for infusion

DRUG2 trials

Sponsors

Institut Curie, Immunogen Inc.

Conditions

Ocular conservative treatment for retinoblastomaPlatinum-Resistant Advanced High-Grade Epithelial OvarianPrimary Peritonealor Fallopian Tube Cancers with High Folate Receptor-Alpha Expression

Phase 2

RETINO 2018: conservative treatment for retinoblastoma: efficacy of the new management strategies and visual outcome

RecruitingCTIS2024-514025-30-00

Institut CurieOcular conservative treatment for retinoblastoma

Start: 2021-03-25Target: 225Updated: 2024-05-31

Phase 3

MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator’s Choice of Chemotherapy in Platinum- Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers with High Folate Receptor-Alpha Expression

CompletedCTIS2024-516111-25-00

Immunogen Inc.or Fallopian Tube Cancers with High Folate Receptor-Alpha Expression, Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal

Start: 2020-11-09End: 2024-10-29Target: 1Updated: 2024-10-15